glp-1 agonist in esrd Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials π΄SGLT2 Inhibitors and GLP-1 Receptor
Description
GLP-1RAs can have effects on inflammation and defending ER stress via suppressing NF-B in diabetic cardiomyocyte models [152]
What began as a diabetes treatment story has rapidly evolved into a broader metabolic health transformation
Endocr Pract 29(5):305340
Retatrutide may well be the therapy that bridges the gap between cutting-edge research and real-world transformationsignaling the future of personalized metabolic care
When P.B
